Wynn Resorts, TuSimple, Newell Brands, First Solar and more

This photo taken on October 20, 2022 shows signs of the Wynn Casino resort in Macau with Grand Lisboa and Casino Lisboa in the background.

Eduardo Leal | AFP | Getty Images

Learn about the companies making headlines in mid-day trading.

Wynn Resorts — Shares of the casino operator rose 10% after a filing showed billionaire investor and restaurant owner Tillman Fertitta holds a passive 6.1% stake in the company. The stock is still down more than 20% this year.

newell brands Shares of consumer goods maker Newell Brands slipped 7.3%. The company was recently downgraded by several analysts including Raymond James, Deutsche Bank, Jefferies and Wells Fargo following its earnings report last week.

TuSimple Self-driving startup TuSimple’s shares fell 46% after it fired its CEO, Xiaodi Hou. An internal investigation showed unfair treatment by Hou and a possible technology transfer to a Chinese firm. The Wall Street Journal reported that both the FBI and the Securities and Exchange Commission are investigating.

First Solar — Solar stock jumped more than 9% during afternoon trading. On Friday, Bank of America raised its price objective on First Solar, according to analysts, saying the company’s growth prospects remain intact after a more than 60% rally this year.

Also Read :  Indians Lured To Thailand Under Pretext Of Jobs Held Captive In Myanmar, Made To Commit Cybercrimes

Paramount Global Shares of Paramount Global fell 3.6% after Wells Fargo Securities was downgraded to less than equal weight. Analyst Steven Kahl, who downgraded the media company to equal weight earlier this month, expects negative revisions and a possible rethink on sports rights or a change in strategy from Paramount.

Hansbrands Inc. Hansbrands shares fell more than 4% after the retailer received a double downgrade from Wells Fargo. The firm lowered the stock from overweight the following year, citing growing macroeconomic and balance sheet issues.

meta platform – Shares of Meta Platforms fell 5.5%, following disappointing earnings results last week as megacap technology shares tumbled. Alphabet, Apple And Microsoft All slipped about 1%.

global payment — The stock slipped 6.7% after the company reported earnings per share that fell in line with expectations and beat anticipated revenue. Meanwhile, the company said it was taking steps to finance multi-billion dollar transactions involving debt. The stock is still up about 7% this month.

Also Read :  Business news in brief

align technology — Align Technology stock jumped 4% on Monday after the company announced a $200 million accelerated share buyback agreement as part of its $1 billion repurchase program.

Haumet Aerospace — Shares of Hommett Aerospace, an aerospace maker, fell more than 3% on Monday after the company reported quarterly results that missed Wall Street’s expectations for revenue. According to StreetAccount, the company reported revenue of $1.43 billion in the quarter, where analysts were expecting $1.44 billion.

NOV Inc. — Shares of oil and gas maker NOV rose more than 5% after Morgan Stanley raised its price target for the company. The firm has a similar weighting rating on the stock.

Oil and energy stocks – The Organization of the Petroleum Exporting Countries said on Monday that oil and energy company stocks rallied on rising demand for oil over the next few decades and called for trillions of dollars of investment in the sector. shares of Kotera Energy 2% added. Diamondback And Occidental Petroleum increased by about 1%.

Also Read :  What Should A Business Do With Extra Cash?

on semiconductor Shares of ON Semiconductor fell more than 8% even after beating estimates on the company’s top and bottom lines. According to StreetAccount, the company’s fourth-quarter guidance was mostly in line, though it called for a gradual decline in revenue. Other chip stocks were also under pressure on Monday, with Advanced Micro Devices down 3.1%.

amgen — Biopharma stock fell 1.5% after Barclays underperformed Amgen by similar weight, saying investors’ enthusiasm may be high ahead of an obesity drug update next week. Amgen shares rose nearly 20% this month, creating a “challenging setup” for the stock to outperform after the update, according to the firm.

— CNBC’s Yoon Lee, Alex Haring, Michelle Fox, Sarah Min and Jesse Pound contributed reporting.


Leave a Reply

Your email address will not be published.